chikusetsusaponin IV

an alpha-glucosidase ligand; isolated from Panax japonicus; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Non-alcoholic Fatty Liver Disease 11/01/2021 - "Validation showed that perillen, chikusetsusaponin IV and trametinib confer disease-relevant impacts against obesity, hyperuricemia and nonalcoholic steatohepatitis, respectively. "
2.	Hyperuricemia 11/01/2021 - "Validation showed that perillen, chikusetsusaponin IV and trametinib confer disease-relevant impacts against obesity, hyperuricemia and nonalcoholic steatohepatitis, respectively. "
3.	Obesity 11/01/2021 - "Validation showed that perillen, chikusetsusaponin IV and trametinib confer disease-relevant impacts against obesity, hyperuricemia and nonalcoholic steatohepatitis, respectively. "
4.	Neoplasms (Cancer) 06/01/2022 - "Characterization of chikusetsusaponin IV and V induced apoptosis in HepG2 cancer cells."

1.	trametinib